Showing results (2261-2270 of 2,830) with videos related to
Sort By:
Pageof 283
American Journal of Physiology. Renal Physiology|February 9, 2007
Alix (AIP1) is a vasopressin receptor (V2R)-interacting protein that increases lysosomal degradation of the V2RXianhua Yi, Richard Bouley, Herbert Y Lin, et al.Journal of Molecular Biology|December 3, 2016
Free Energy Perturbation Calculation of Relative Binding Free Energy between Broadly Neutralizing Antibodies and the gp120 Glycoprotein of HIV-1Anthony J Clark, Tatyana Gindin, Baoshan Zhang, et al.Acta Crystallographica. Section D, Biological Crystallography|April 20, 2000
The structure of human aldose reductase bound to the inhibitor IDD384V Calderone, B Chevrier, M Van Zandt, et al.Science (New York, N.Y.)|August 19, 2000
Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3H Li, S K Kolluri, J Gu, et al.The American Journal of Pathology|August 10, 2000
Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivoD L Lacey, H L Tan, J Lu, et al.Oncogene|November 29, 2016
TGFβ promotes mesenchymal phenotype of pancreatic cancer cells, in part, through epigenetic activation of VAV1P-H Huang, P-J Lu, L-Y Ding, et al.Journal of Environmental Quality|July 4, 2012
Effects of reed straw, zeolite, and superphosphate amendments on ammonia and greenhouse gas emissions from stored duck manureJ Z Wang, Z Y Hu, X Q Zhou, et al.Journal of Drug Targeting|March 28, 2008
Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIaMamoru Shoji, Aiming Sun, Walter Kisiel, et al.Journal of Biotechnology|February 5, 2008
CNTO 530: molecular pharmacology in human UT-7EPO cells and pharmacokinetics and pharmacodynamics in miceP J Bugelski, R J Capocasale, D Makropoulos, et al.Journal of Biological Regulators and Homeostatic Agents|July 1, 2016
Multicenter study of autoverification methods of hematology analysisX Zhao, X F Wang, J B Wang, et al.Pageof 283